Epstein & White Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-946
Closed -$224K 78
2020
Q2
$224K Sell
946
-1,121
-54% -$256K 0.08% 67
2020
Q1
$419K Sell
2,067
-943
-31% -$206K 0.18% 40
2019
Q4
$722K Buy
+3,010
New +$663K 0.32% 32

Other funds holding AMGN

Epstein & White Financial's AMGN Position: Q3 2020 in Review

Epstein & White Financial sold out of Amgen (AMGN) in Q3 2020, closing a stake of 946 shares — an estimated $224K sold.

Epstein & White Financial first reported a position in AMGN in Q4 2019 and held it in 3 quarters. The position peaked at $722K in Q4 2019. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Epstein & White Financial reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Epstein & White Financial sold 946 Amgen shares in Q3 2020, an estimated $224K.
  • Epstein & White Financial first reported a position in Amgen in Q4 2019 and held it in 3 quarters.
  • Epstein & White Financial's Amgen position peaked at $722K in Q4 2019.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Epstein & White Financial's 13F filing for Q3 2020, filed 14 Oct 2020.